Findings by Sylvester Researchers Point to New Therapeutic Target for Advanced Prostate Cancer 07.18.2019
The Burnstein lab at Sylvester Comprehensive Cancer Center, along with collaborators at Moffitt Cancer Center and the University of Florida Cancer Center, recently discovered that arginine vasopressin receptor type 1a (AVPR1a) can promote aggressive prostate cancer growth.
An international phase III clinical trial evaluating the drug Arimoclomol for the treatment of amyotrophic lateral sclerosis (ALS) has reached full enrollment, as reported by a University of Miami Miller School of Medicine researcher. The current phase III trial builds upon the results of a prior phase II trial that enrolled patients with a rapidly progressive, rare genetic form of ALS.
Akram Tamer, M.D., came to the University of Miami in 1969 as a resident seeking to advance his knowledge of pediatrics. Through the years, he has cared for young patients and families, conducted significant research and inspired several generations of students, residents and faculty at the Miller School of Medicine through his teaching.
A group of researchers from Sylvester Comprehensive Cancer Center, the Department of Surgery and the Department of Medicine at the University of Miami Miller School of Medicine have found that probiotics can reduce morphine tolerance when used as an adjunct therapy in germ-free mice.
Sarah Christensen, a fundraising and development executive with a track record for orchestrating strategic growth in the area of philanthropy, has been named the new vice president for medical development and alumni relations, the University of Miami announced Wednesday.
Cigarette smoking is one of the major risk factors for pancreatic cancer and a focus of study for Sylvester Comprehensive Cancer Center researchers Vikas Dudeja, M.D., and Sulagna Banerjee, Ph.D. Their individual research projects, recently awarded state funding, examine different tobacco-related mechanisms that promote or drive this aggressive cancer.
In the battle to fight cancer, and to identify cures that not only save patients but also improve their quality of life, Sylvester Comprehensive Cancer Center at the University of Miami Leonard M. Miller School of Medicine and the Pap Corps, Champions for Cancer Research, have forged a remarkable partnership close to 70 years strong.
A clinical team from the University of Miami Miller School of Medicine’s Comprehensive Epilepsy Center and the Department of Neurosurgery recently performed Florida’s second deep brain stimulation (DBS) surgery for a patient with intractable epilepsy. The new treatment, which was approved by the U.S. Food and Drug Administration in 2018, offers a new therapeutic strategy for patients whose epilepsy cannot be treated effective
Dr. Monica Broome Receives Exceptional Mentor Award from American Medical Women’s Association 07.08.2019
Monica Broome, M.D., assistant professor of medicine and director of the University of Miami Miller School of Medicine’s Communications Skills Program, has received the Exceptional Mentor Award from the American Medical Women’s Association (AMWA).
The National Institutes of Health has awarded University of Miami researchers $14 million for an ambitious seven-year project that will keep the Miller School of Medicine at the forefront of cutting-edge HIV research. The research will track cardiovascular and pulmonary disease as well as other non-infectious conditions that people with HIV – both women and men – experience as they age.